Aegerion - Xconomy

by in

Entry	Author	Date	Location
FDA Staff Issues Positive Report for Aegerion’s Lomatapide	Catherine Arnst	10/15/12	Boston
Biotech Racking Up Successes Against Ultra-Orphan Diseases	Catherine Arnst	10/15/12	New York
Xconomy Boston’s Top 20 Stories of Q3 2012: Editor’s Picks	Gregory T. Huang	09/28/12	Boston
Infinity & Dicerna Among the Week’s Life Sciences Newsmakers	Erin Kutz	08/10/12	Boston
Two Years After Rising from Ashes, Aegerion Preps for Drug Debut	Arlene Weintraub	08/09/12	Boston
Page 1 of 1

Xconomy National